EUVIMEDEUVIMED entdecken
Crossref

Copper-Based Nanoparticle Co-Loaded with Natural PD-L1 Inhibitor and 5-Fluorouracil for Enhanced Immunotherapy of Hepatocellular Carcinoma

Hongwu Huang iD, Bingcong Peng, Xuan Zhao, Xiangyu Chen, Dongxiu He

Molecular Pharmaceutics · 2026

DOI: 10.1021/acs.molpharmaceut.5c01574 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecular Pharmaceutics, 2026. Verfasst von Hongwu Huang und 4 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmaceutical Science, Hengyang Medical School, University of South China, Hengyang 421001, Hunan China. Hauptthemen laut MEDLINE: Fluorouracil, Carcinoma, Hepatocellular, Liver Neoplasms, Copper. Die Arbeit nennt 58 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Despite the revolutionary breakthroughs in immunotherapy for hepatocellular carcinoma, its efficacy remains limited due to low tumor immunogenicity, insufficient immune cell infiltration, and an immunosuppressive tumor microenvironment. To address these challenges, we developed a novel copper-based nanoparticle designed for the synergistic delivery of the chemotherapeutic agent 5-fluorouracil (5-FU) and the natural programmed cell death ligand 1 (PD-L1) inhibitor chrysin (Chr). This nanosystem facilitates the targeted accumulation of these drugs at the tumor site and enables the responsive release of 5-FU, copper ions, and Chr in an acidic environment, thereby synergistically activating antitumor immune responses through the induction of cuproptosis, promotion of immunogenic cell death (ICD), and downregulation of PD-L1 expression. In vitro experiments demonstrated that this nanoparticle reduced the half-maximal inhibitory concentration (IC50) for Hepa1-6 cells by approximately 3.0 times compared with the administration of 5-FU alone. In vivo experiments revealed significant tumor suppression effects with an inhibition rate reaching as high as 89.8%. Notably, this nanoparticle successfully activated systemic antitumor immunity, as evidenced by a dendritic cell maturation rate of 32.9% in lymph nodes and a CD8+ T cell infiltration rate of 28.3% within the tumor microenvironment. This study presents an efficient nanomedicine strategy that synergistically induces cuprotosis and ICD and inhibits PD-L1 expression, thereby providing a new direction for enhancing immunotherapy in hepatocellular carcinoma.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

FluorouracilCarcinoma, HepatocellularLiver NeoplasmsCopperB7-H1 AntigenNanoparticlesImmune Checkpoint InhibitorsAnimalsImmunotherapyMiceHumansCell Line, TumorCuproptosisFlavonoidsTumor Microenvironment

Stichwörter der Autor:innen

cuproptosishepatocellular carcinomaimmunotherapynanoparticlenatural PD-L1 inhibitor

Substanzen

FluorouracilCopperB7-H1 AntigenFlavonoidschrysinImmune Checkpoint InhibitorsCD274 protein, human

Autor:innen und Institutionen

  • School of Pharmaceutical Science, Hengyang Medical School, University of South China, Hengyang 421001, Hunan China.

ORCID-Profile: Hongwu Huang

Zitieren

APA

Huang, H., Peng, B., Zhao, X., Chen, X., & He, D. (2026). Copper-Based Nanoparticle Co-Loaded with Natural PD-L1 Inhibitor and 5-Fluorouracil for Enhanced Immunotherapy of Hepatocellular Carcinoma. Molecular Pharmaceutics. https://doi.org/10.1021/acs.molpharmaceut.5c01574

Vancouver

Huang H, Peng B, Zhao X, Chen X, He D. Copper-Based Nanoparticle Co-Loaded with Natural PD-L1 Inhibitor and 5-Fluorouracil for Enhanced Immunotherapy of Hepatocellular Carcinoma. Molecular Pharmaceutics. 2026. doi:10.1021/acs.molpharmaceut.5c01574

BibTeX
@article{Huang2026,
  author = {Huang, Hongwu and Peng, Bingcong and Zhao, Xuan and Chen, Xiangyu and He, Dongxiu},
  title = {Copper-Based Nanoparticle Co-Loaded with Natural PD-L1 Inhibitor and 5-Fluorouracil for Enhanced Immunotherapy of Hepatocellular Carcinoma},
  journal = {Molecular Pharmaceutics},
  year = {2026},
  doi = {10.1021/acs.molpharmaceut.5c01574}
}
Kostenlos starten →